HLA class II diversity in HIV-1 uninfected individuals from the placebo arm of the RV144 Thai vaccine efficacy trial

The RV144 HIV vaccine trial in Thailand elicited antibody responses to the envelope of HIV-1, which correlated significantly with the risk of HIV-1 acquisition. Human leukocyte antigen (HLA) class II molecules are essential in antigen presentation to CD4 T cells for activation of B cells to produce...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Tissue Antigens
Päätekijät: Baldwin, Karen M., Ehrenberg, Philip K., Geretz, Aviva, Prentice, Heather A., Nitayaphan, Sorachai, Rerks-Ngarm, Supachai, Kaewkungwal, Jaranit, Pitisuttithum, Punnee, O’Connell, Robert J., Kim, Jerome H., Thomas, Rasmi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4552183/
https://ncbi.nlm.nih.gov/pubmed/25626602
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tan.12507
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia